BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 24461310)

  • 21. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration.
    Sin HP; Liu DT; Lam DS
    Acta Ophthalmol; 2013 Feb; 91(1):6-11. PubMed ID: 22268800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
    Evans JR; Lawrenson JG
    Cochrane Database Syst Rev; 2012 Jun; (6):CD000253. PubMed ID: 22696317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The age-related eye disease study: the results of the clinical trial.
    Sackett CS; Schenning S
    Insight; 2002; 27(1):5-7. PubMed ID: 11962062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential preventive effects of vitamins for cataract and age-related macular degeneration.
    Jacques PF
    Int J Vitam Nutr Res; 1999 May; 69(3):198-205. PubMed ID: 10389028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Macular pigment and age-related macular degeneration. Clinical implications].
    Haddad WM; Souied E; Coscas G; Soubrane G
    Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Wang JJ; Flood V; Rochtchina E; Smith W; Mitchell P
    Ophthalmology; 2008 Feb; 115(2):334-41. PubMed ID: 17664009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
    Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
    JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivitamin/mineral supplements and prevention of chronic disease.
    Huang HY; Caballero B; Chang S; Alberg A; Semba R; Schneyer C; Wilson RF; Cheng TY; Prokopowicz G; Barnes GJ; Vassy J; Bass EB
    Evid Rep Technol Assess (Full Rep); 2006 May; (139):1-117. PubMed ID: 17764205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Micronutrients and their relevance for the eye--function of lutein, zeaxanthin and omega-3 fatty acids].
    Schweigert FJ; Reimann J
    Klin Monbl Augenheilkd; 2011 Jun; 228(6):537-43. PubMed ID: 20740395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration.
    Merle BM; Benlian P; Puche N; Bassols A; Delcourt C; Souied EH;
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):2010-9. PubMed ID: 24557349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
    Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
    JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional supplements in age-related macular degeneration.
    Schmidl D; Garhöfer G; Schmetterer L
    Acta Ophthalmol; 2015 Mar; 93(2):105-21. PubMed ID: 25586104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional supplements for age-related macular degeneration.
    Krishnadev N; Meleth AD; Chew EY
    Curr Opin Ophthalmol; 2010 May; 21(3):184-9. PubMed ID: 20216418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
    Merle BMJ; Buaud B; Korobelnik JF; Bron A; Delyfer MN; Rougier MB; Savel H; Vaysse C; Creuzot-Garcher C; Delcourt C
    Acta Ophthalmol; 2017 Dec; 95(8):e763-e769. PubMed ID: 28271618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
    Chiu CJ; Milton RC; Klein R; Gensler G; Taylor A
    Ophthalmology; 2009 May; 116(5):939-46. PubMed ID: 19410952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of different nutrients in age-related macular degeneration: A systematic review and network meta-analysis.
    Li SS; Wang HH; Zhang D
    Semin Ophthalmol; 2022 May; 37(4):515-523. PubMed ID: 34995151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary intake of antioxidants and risk of age-related macular degeneration.
    van Leeuwen R; Boekhoorn S; Vingerling JR; Witteman JC; Klaver CC; Hofman A; de Jong PT
    JAMA; 2005 Dec; 294(24):3101-7. PubMed ID: 16380590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vitamins for prevention of age related macular degeneration: efficacy and risk].
    Cohen SY
    Bull Soc Belge Ophtalmol; 2006; (301):33-6. PubMed ID: 17552430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.